Study of ZIO-201 in Advanced Sarcoma

StatusCompleted
PhasePhase 1/2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv10
  2. Primary endpoint revised
    • Enrollment target: 53 to 54
    • Secondary endpoints: 1 to 2
    • Study arms: 1 to 2
    v9
  3. Primary completion date: Jun 2008 to Jan 16, 2008
    • Study completion date: Dec 2013 to Jan 16, 2008
    • Start date: Feb 2006 to Feb 21, 2006
    v8
  4. Primary completion date: Mar 2008 to Jun 2008
    • Study completion date: Mar 2008 to Dec 2013
    v7
  5. Enrollment target: estimated 40 to confirmed 53v6
Show 4 earlier versionsHide 4 earlier versions
  1. Trial status: Active, Not Recruiting to Completedv5
  2. 2 versions Re-verified since Aug 22, 2008, no change to tracked fieldsv3-v4
  3. Trial status: Recruiting to Active, Not Recruitingv2 Show 5 more changesShow less
    • Enrollment target: 40
    • Study sites: 1 to 2
    • Primary and study completion dates: Mar 2008
    • Start date: Feb 2006
    • Study arms: 0 to 1
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Alaunos Therapeutics
18 trials monitored
See all monitored trials
Sarcoma
1,029 trials monitored
See 72 trials at risk
The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.
Trial Details
NCT Number NCT00439686
Lead Sponsor Alaunos Therapeutics
Conditions
(from sponsor)		 Advanced Sarcoma
Enrollment 54 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov